Literature DB >> 14597440

Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer.

Isabelle Bedrosian1, Deepak Bedi, Henry M Kuerer, Bruno D Fornage, Lori Harker, Merrick I Ross, Frederick C Ames, Savitri Krishnamurthy, Beth S Edeiken-Monroe, Funda Meric, Barry W Feig, Jeri Akins, S Eva Singletary, Nadeem Q Mirza, Kelly K Hunt.   

Abstract

BACKGROUND: Ultrasonography and fine-needle aspiration (FNA) are used to evaluate the breast and regional nodes in breast cancer patients. We sought to identify factors influencing the sensitivity of ultrasonography for detection of nodal metastasis.
METHODS: Patients with a clinically negative axilla who underwent axillary ultrasonography and sentinel lymph node biopsy were included.
RESULTS: Of 208 patients, axillary ultrasonography was negative in 180 (86%) and suspicious or indeterminate in 28 (14%). FNA was performed in 22 patients whose findings were indeterminate or suspicious, and 3 were positive for malignancy. Final pathological examinations revealed positive nodes in 53 patients: 39 (22%) of 180 with negative ultrasonographic findings and 14 (50%) of 28 with indeterminate or suspicious ultrasonographic findings (P =.001). Excisional biopsy was more common for patients with indeterminate or suspicious findings on preoperative ultrasonography (P =.038). There were no significant differences in tumor size, histological features, size of nodal metastasis, or number of positive nodes between patients whose ultrasonography findings were negative and those whose findings were indeterminate or suspicious.
CONCLUSIONS: Ultrasonographically suggested nodal metastasis is associated with the finding of nodal disease on final pathological examination. No significant clinicopathologic criteria were found to impact sensitivity of ultrasonography; however, excisional biopsy for diagnosis may be a confounding variable in subsequent axillary ultrasonography.

Entities:  

Mesh:

Year:  2003        PMID: 14597440     DOI: 10.1245/aso.2003.12.017

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  [Non-invasive imaging modalities for preoperative axillary lymph node staging in patients with breast cancer].

Authors:  K Wasser; A Schnitzer; J Brade; S O Schoenberg
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

Review 2.  Is imaging the future of axillary staging in breast cancer?

Authors:  M Ahmed; S I Usiskin; M A Hall-Craggs; Michael Douek
Journal:  Eur Radiol       Date:  2013-09-14       Impact factor: 5.315

Review 3.  New horizons for imaging lymphatic function.

Authors:  Ruchi Sharma; Juliet A Wendt; John C Rasmussen; Kristen E Adams; Milton V Marshall; Eva M Sevick-Muraca
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 4.  Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review.

Authors:  Jonathan Cools-Lartigue; Sarkis Meterissian
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

5.  The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer.

Authors:  Puneeth Iyengar; Eric A Strom; Yu-Jing Zhang; Gary J Whitman; Benjamin D Smith; Wendy A Woodward; Tse-Kuan Yu; Thomas A Buchholz
Journal:  Oncologist       Date:  2012-09-14

6.  Assessing health care use and cost consequences of a new screening modality: the case of digital mammography.

Authors:  Louise M Henderson; Rebecca A Hubbard; Tracy L Onega; Weiwei Zhu; Diana S M Buist; Paul Fishman; Anna N A Tosteson
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

7.  Incremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer.

Authors:  Rosalind P Candelaria; Monica L Huang; Beatriz E Adrada; Roland Bassett; Kelly K Hunt; Henry M Kuerer; Benjamin D Smith; Mariana Chavez-MacGregor; Wei Tse Yang
Journal:  Acad Radiol       Date:  2016-12-07       Impact factor: 3.173

8.  Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients.

Authors:  Dana M Holwitt; Mary Ellen Swatske; William E Gillanders; Barbara S Monsees; Feng Gao; Rebecca L Aft; Timothy J Eberlein; Julie A Margenthaler
Journal:  Am J Surg       Date:  2008-08-23       Impact factor: 2.565

9.  Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.

Authors:  Amy E Cyr; Natalia Tucker; Foluso Ademuyiwa; Julie A Margenthaler; Rebecca L Aft; Timothy J Eberlein; Catherine M Appleton; Imran Zoberi; Maria A Thomas; Feng Gao; William E Gillanders
Journal:  J Am Coll Surg       Date:  2016-05-20       Impact factor: 6.113

10.  Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients.

Authors:  Jung Hyun Yoon; Kyung Hwa Han; Eun-Kyung Kim; Hee Jung Moon; Min Jung Kim; Young Joo Suh; Ji Soo Choi; Byeong-Woo Park
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.